Individuals with homozygous deletions of GSTM1 or GSTT1 lack GSTs and therefore may be unable to eliminate electrophilic carcinogens efficiently, which may increase the risk of somatic mutations that lead to tumor formation. The gene discussed is HPGDS; the disease is neoplasm.